Meds A-Z
Selamectin
Detailed information about Selamectin
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
revolution® PLUS is indicated for the prevention of heartworm disease caused by Dirofilaria immitis , the treatment and control of roundworm ( Toxocara cati ) and intestinal hookworm ( Ancylostoma tubaeforme ) infections...
What it does:
Revolution kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the preventionand control of flea infestations ( Ctenocephalides felis ), prevention of heartworm disease caused by Dir...
When it's needed:
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in sick, debilitated, or underweight animals.
Call your vet sooner if you notice:
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in sick, debilitated, or underweight animals.
Commonly reported reactions:
- (1 reports)
- (1 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Selamectin
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: MSK
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141502 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200769 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in sick, debilitated, or underweight animals.
- High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in sick, debilitated, or underweight animals.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 1 | Dog | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Dog | 1 | |
| 1 | Cat | 1 | |
| 1 | Dog | 0 | |
| 1 | Cat | 0 | |
| 1 | Cat | 0 |
Species coverage: Cat (27) Dog (5)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Cat | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-055194
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 28 • Secondary summaries: 0
- FOI Summary sN 141-502 Approved November 13, 2024.pdf · FOI
- FOI Summary sN 141-502 Approved December 14, 2023.pdf · FOI
- FOI Summary oN 141-502 Approved November 9, 2018.pdf · FOI
- revolution® PLUS · SPL
- FOI Summary oA 200-769 Approved January 30, 2024.pdf · FOI
- Selamectin · SPL
- FOI Summary oA 200-670 Approved March 10, 2020.pdf · FOI
- CIS SENERGY A200670G0003.pdf · Labeling
- PI SENERGY A200670G0003.pdf · Labeling
- SENERGY™ · SPL
- FOI Summary oA 200-663 Approved November 20, 2019.pdf · FOI
- CIS SELARID A200663G0001.pdf · Labeling
- Package Insert SELARID A200663G0001.pdf · Labeling
- Selarid® · SPL
- FOI Summary oA 200-673 Approved April 22, 2020.pdf · FOI
- REVOLT A200673G0003.pdf · Labeling
- REVOLT A200673G0003.pdf · Labeling
- Revolt® · SPL
- ucm117204.pdf · FOI
- ucm117203.pdf · FOI
- ucm117201.pdf · FOI
- Final Version REVOLUTION N141152C0093.pdf · Labeling
- Final Version REVOLUTION N141152C0093.pdf · Labeling
- Revolution® · SPL
- FOI Summary oA 200-696 Approved December 16, 2020.pdf · FOI
- CIS SELASPOT A200696A0000-2.pdf · Labeling
- PI SELASPOT A200696A0000.pdf · Labeling
- SelaSpot™ · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/16247 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14844 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/5847 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/5609/revolution%C2%AE%20PLUS · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14985 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/15223/Selamectin · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/8527 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/907 · document · Labeling
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/908 · document · Labeling
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/8609/SENERGY%E2%84%A2 · document · SPL
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:02 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:19 AM UTC
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in sick, debilitated, or underweight animals. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 13985-966-15 | 13985 | - | |
| 13985-966-45 | 13985 | - | |
| 13985-966-60 | 13985 | - | |
| 13985-967-12 | 13985 | - | |
| 13985-967-20 | 13985 | - | |
| 13985-967-30 | 13985 | - | |
| 13985-967-60 | 13985 | - | |
| 20076-0000-3 | 20076 | - | |
| 20076-0000-4 | 20076 | - | |
| 50989-317-99 | 50989 | - | |
| 50989-318-99 | 50989 | - | |
| 50989-319-99 | 50989 | - | |
| 50989-320-99 | 50989 | - | |
| 50989-321-99 | 50989 | - | |
| 50989-322-99 | 50989 | - | |
| 50989-323-99 | 50989 | - | |
| 50989-324-99 | 50989 | - | |
| 51072-097-01 | 51072 | - | |
| 51072-097-02 | 51072 | - | |
| 51072-097-03 | 51072 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
FOI Summary oN 141-502 Approved November 9, 2018.pdf
• FOI summary • Official
• Dec. 2, 2024
FDA FOI summary for application 141502
-
FOI Summary sN 141-502 Approved December 14, 2023.pdf
• FOI summary • Official
• Dec. 2, 2024
FDA FOI summary for application 141502
-
FOI Summary sN 141-502 Approved November 13, 2024.pdf
• FOI summary • Official
• Dec. 2, 2024
FDA FOI summary for application 141502
-
FOI Summary oA 200-769 Approved January 30, 2024.pdf
• FOI summary • Official
• Feb. 1, 2024
FDA FOI summary for application 200769
-
PI SENERGY A200670G0003.pdf
• Official label • Official
• Oct. 24, 2023
FDA official labeling for application 200670
-
CIS SENERGY A200670G0003.pdf
• Official label • Official
• Oct. 24, 2023
FDA official labeling for application 200670
-
FOI Summary oA 200-670 Approved March 10, 2020.pdf
• FOI summary • Official
• Oct. 24, 2023
FDA FOI summary for application 200670
-
Package Insert SELARID A200663G0001.pdf
• Official label • Official
• Sept. 7, 2023
FDA official labeling for application 200663
-
CIS SELARID A200663G0001.pdf
• Official label • Official
• Sept. 7, 2023
FDA official labeling for application 200663
-
FOI Summary oA 200-663 Approved November 20, 2019.pdf
• FOI summary • Official
• Sept. 7, 2023
FDA FOI summary for application 200663
-
REVOLT A200673G0003.pdf
• Official label • Official
• June 7, 2021
FDA official labeling for application 200673
-
REVOLT A200673G0003.pdf
• Official label • Official
• June 7, 2021
FDA official labeling for application 200673
-
FOI Summary oA 200-673 Approved April 22, 2020.pdf
• FOI summary • Official
• June 7, 2021
FDA FOI summary for application 200673
-
PI SELASPOT A200696A0000.pdf
• Official label • Official
• May 17, 2021
FDA official labeling for application 200696
-
CIS SELASPOT A200696A0000-2.pdf
• Official label • Official
• May 17, 2021
FDA official labeling for application 200696
-
FOI Summary oA 200-696 Approved December 16, 2020.pdf
• FOI summary • Official
• May 17, 2021
FDA FOI summary for application 200696
-
Final Version REVOLUTION N141152C0093.pdf
• Official label • Official
• May 17, 2021
FDA official labeling for application 141152
-
Final Version REVOLUTION N141152C0093.pdf
• Official label • Official
• May 17, 2021
FDA official labeling for application 141152
-
ucm117201.pdf
• FOI summary • Official
• May 17, 2021
FDA FOI summary for application 141152
-
ucm117203.pdf
• FOI summary • Official
• May 17, 2021
FDA FOI summary for application 141152
-
ucm117204.pdf
• FOI summary • Official
• May 17, 2021
FDA FOI summary for application 141152
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in sick, debilitated, or underweight animals. (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Lack of efficacy (ectoparasite) - flea, Lack of efficacy (endoparasite) - heartworm, Vomiting, Lethargy (see also Central ner… (Official, 2026-02-12)
- usage: Revolution kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the preventionand control of flea infestations ( Ctenoceph… (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
revolution® PLUS
RX
Sarolaner Selamectin
Topical Solution
• Topical
|
Zoetis Inc. | NADA 141-502 | Approved | Dec 2, 2024 |
|
Selamectin
RX
Selamectin
Topical Solution
• Topical
|
ZYVET AH, Inc. | ANADA 200-769 | Approved | Feb 1, 2024 |
|
SENERGY™
RX
Selamectin
Topical Solution
• Topical
|
Virbac AH, Inc. | ANADA 200-670 | Approved | Oct 24, 2023 |
|
Selarid®
RX
Selamectin
Topical Solution
• Topical
|
Norbrook Laboratories, Ltd. | ANADA 200-663 | Approved | Sep 7, 2023 |
|
Revolt®
RX
Selamectin
Topical Solution
• Topical
|
Aurora Pharmaceutical, Inc. | ANADA 200-673 | Approved | Jun 7, 2021 |
|
Revolution®
RX
Selamectin
Liquid
• Topical
|
Zoetis Inc. | NADA 141-152 | Approved | May 17, 2021 |
|
SelaSpot™
RX
Selamectin
Topical Solution
• Topical
|
Bimeda Animal Health Limited | ANADA 200-696 | Approved | May 17, 2021 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
revolution® PLUS is indicated for the prevention of heartworm disease caused by Dirofilaria immitis, the treatment and control of roundworm (Toxocara cati) and intestinal hookworm (Ancylostoma tubaeforme) infections, and the treatment and control of ear mite (Otodectes cynotis) infestations. revolution® PLUS kills adult fleas (Ctenocephalides felis) and is indicated for the treatment and prevention of flea infestations, the prevention of Dipylidium caninum (tapeworm) infections as a direct result of killing Ctenocephalides felis vector fleas on the treated cat, and the treatment and control of tick infestations with Amblyomma americanum (lone star tick), Amblyomma maculatum (Gulf Coast tick), Dermacentor variabilis (American dog tick), and Ixodes scapularis (black-legged tick) for one month in cats and kittens 8 weeks and older, and weighing 2.8 pounds or greater.
The recommended minimum dosage is 2.7 mg selamectin per pound (6.0 mg/kg) of body weight in combination with 0.45 mg sarolaner per pound (1.0 mg/kg) of body weight administered monthly.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of sarcoptic mange (Sarcoptes scabiei) and for the control of tick infestations due to Dermacentor variabilis.
.
The recommended minimum dose is 2.7 mg selamectin per pound (6 mg/kg) of body weight.
Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of roundworm (Toxocara cati) and intestinal hookworm (Ancylostoma tubaeforme) infections in cats.
The recommended minimum dose is 2.7 mg selamectin per pound (6 mg/kg) of body weight.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of sarcoptic mange (Sarcoptes scabiei) and for the control of tick infestations due to Dermacentor variabilis.
The recommended minimum dose is 2.7 mg selamectin per pound (6 mg/kg) of body weight.
Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of roundworm (Toxocara cati) and intestinal hookworm (Ancylostoma tubaeforme) infections in cats.
The recommended minimum dose is 2.7 mg selamectin per pound (6 mg/kg) of body weight.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Kills adult fleas and prevents flea eggs from hatching for 1 month, and it is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and treatment and control of ear mite (Otodectes cynotis) infestations. Treatment and control of sarcoptic mange (Sarcoptes scabiei) and control of tick infestations due to Dermacentor variabilis.
2.7 milligrams of selamectin, topically, per pound (6 milligrams per kilogram) of body weight.
Kills adult fleas and prevents flea eggs from hatching for 1 month, and it is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and treatment and control of ear mite (Otodectes cynotis) infestations. Treatment and control of intestinal hookworm (Ancylostoma tubaeforme) and roundworm (Toxocara cati) infections.
2.7 milligrams of selamectin, topically, per pound (6 milligrams per kilogram) of body weight.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of sarcoptic mange (Sarcoptes scabiei) and for the control of tick infestations due to Dermacentor variabilis.
The recommended minimum dose is 2.7 mg selamectin per pound (6 mg/kg) of body weight.
Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of roundworm (Toxocara cati) and intestinal hookworm (Ancylostoma tubaeforme) infections in cats.
The recommended minimum dose is 2.7 mg selamectin per pound (6 mg/kg) of body weight.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Revolution kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the preventionand control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilariaimmitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. Revolution is also indicatedfor the treatment and control of roundworm (Toxocara cati) and intestinal hookworm (Ancylostoma tubaeforme)infections in cats.
Revolution kills adult fleas and prevents flea eggs from hatching for one month andis indicated for the prevention and control of flea infestations (Ctenocephalidesfelis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment andcontrol of ear mite (Otodectes cynotis) infestations. Revolution also is indicated forthe treatment and control of sarcoptic mange (Sarcoptes scabiei) and for the controlof tick infestations due to Dermacentor variabilis.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
In dogs six weeks of age or older, kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of sarcoptic mange (Sarcoptes scabiei) and for the control of tick infestations due to Dermacentor variabilis.
Administer topically 2.7 mg of selamectin per pound (6 mg per kilogram) of body weight.
In cats eight weeks of age and older, kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of roundworm (Toxocara cati) and intestinal hookworm (Ancylostoma tubaeforme) infections in cats.
Administer topically 2.7 mg of selamectin per pound (6 mg per kilogram) of body weight.
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
-
Summary
This supplement provides for the addition of the indication for the prevention of Dipylidium caninum (tapeworm) infections as a direct result of killing Ctenocephalides felis vector fleas on the treated cat for one month in cats and kittens 8 weeks and older, and weighing 2.8 pounds or greater.
-
Summary
This supplement provides for the addition of the indication for the treatment and control of tick infestations with Amblyomma americanum (lone star tick) for one month in cats and kittens 8 weeks and older, and weighing 2.8 pounds or greater.
-
Summary
revolution® PLUS is indicated for the prevention of heartworm disease caused by Dirofilaria immitis. revolution® PLUS kills adult fleas (Ctenocephalides felis)and is indicated for the treatment and prevention of flea infestations, the treatment and control of tick infestations with Ixodes scapularis (black-legged tick), Amblyomma maculatum (Gulf Coast tick) and Dermacentor variabilis (American dog tick), the treatment and control of ear mite (Otodectes cynotis) infestations, and the treatment and control of roundworm (Toxocara cati) and intestinal hookworm (Ancylostoma tubaeforme) infections for one month in cats and kittens 8 weeks and older, and weighing 2.8 pounds or greater.
- revolution® PLUS (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
 Selamectin is recommended for use in dogs six weeks of age or older and cats eight weeks of age and older for the following parasites and indications:
Dogs: Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of sarcoptic mange (Sarcoptes scabiei) and for the control of tick infestations due to Dermacentor variabilis.
Cats: Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of roundworm (Toxocara cati) and intestinal hookworm (Ancylostoma tubaeforme) infections in cats.
- Selamectin (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
Recommended for use in dogs six weeks of age or older and cats eight weeks of age and older for the following parasites and indications:
Dogs: Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of sarcoptic mange (Sarcoptes scabiei) and for the control of tick infestations due to Dermacentor variabilis.
Cats: Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of roundworm (Toxocara cati) and intestinal hookworm (Ancylostoma tubaeforme) infections in cats. -
Labeling CIS SENERGY A200670G0003.pdf
-
Labeling PI SENERGY A200670G0003.pdf
- SENERGY™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For dogs 6 weeks of age and older: Kills adult fleas and prevents flea eggs from hatching for 1 month, and it is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and treatment and control of ear mite (Otodectes cynotis) infestations. Treatment and control of sarcoptic mange (Sarcoptes scabiei ) and control of tick infestations due to Dermacentor variabilis.
For cats 8 weeks of age and older: Kills adult fleas and prevents flea eggs from hatching for 1 month, and it is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and treatment and control of ear mite (Otodectes cynotis ) infestations. Treatment and control of intestinal hookworm (Ancylostoma tubaeforme) and roundworm (Toxocara cati ) infections.
-
Labeling CIS SELARID A200663G0001.pdf
- Selarid® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For use in dogs six weeks of age or older and cats eight weeks of age and older for the following parasites and indications:
Dogs: Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of sarcoptic mange (Sarcoptes scabiei) and for the control of tick infestations due to Dermacentor variabilis.
Cats: Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of roundworm (Toxocara cati) and intestinal hookworm (Ancylostoma tubaeforme) infections in cats.
-
Labeling REVOLT A200673G0003.pdf
-
Labeling REVOLT A200673G0003.pdf
- Revolt® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm117204.pdf
Summary
Provide additional indication for control of intestinal hookworm (Ancylostoma tubaeforme) and roundworm(Toxocara cati) infections in cats. -
FOI ucm117203.pdf
Summary
Provides for the additional indication for control of tick infestations in dogs -
FOI ucm117201.pdf
Summary
Revolution kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations in dogs and cats. Revolution also is indicated for the treatment and control of sarcoptic mange (Sarcoptes scabiei) in dogs, and the treatment of intestinal hookworm (Ancylostoma tubaeforme) and roundworm (Toxocara cati) infections in cats. Revolution is recommended for use in dogs and cats six weeks of age and older.
- Revolution® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For use in dogs six weeks of age or older and cats eight weeks of age and older for the following parasites and indications:
Dogs: Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of sarcoptic mange (Sarcoptes scabiei) and for the control of tick infestations due to Dermacentor variabilis.
Cats: Kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the prevention and control of flea infestations (Ctenocephalides felis), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment and control of ear mite (Otodectes cynotis) infestations. It is also indicated for the treatment and control of roundworm (Toxocara cati) and intestinal hookworm (Ancylostoma tubaeforme) infections in cats.
-
Labeling CIS SELASPOT A200696A0000-2.pdf
-
Labeling PI SELASPOT A200696A0000.pdf
- SelaSpot™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
Usage
Revolution kills adult fleas and prevents flea eggs from hatching for one month and is indicated for the preventionand control of flea infestations ( Ctenocephalides felis ), prevention of heartworm disease caused by Dirofilariaimmitis, and the treatment and control of ear mite ( Otodectes cynotis ) infestations. Revolution is also indicatedfor the treatment and control of roundworm ( Toxocara cati ) and intestinal hookworm ( Ancylostoma tubaeforme )infections in cats. Revolution kills adult fleas and prevents flea eggs from hatching for one month andis indicated for the prevention and control of flea infestations ( Ctenocephalidesfelis ), prevention of heartworm disease caused by Dirofilaria immitis, and the treatment andcontrol of ear mite ( Otodectes cynotis ) infestations. Revolution also is indicated forthe treatment and control of sarcoptic mange ( Sarcoptes scabiei ) and for the controlof tick infestations due to Dermacentor variabilis. revolution® PLUS is indicated for the prevention of heartworm disease caused by Dirofilaria immitis , the treatment and control of roundworm ( Toxocara cati ) and intestinal hookworm ( Ancylostoma tubaeforme ) infections, and the treatment and control of ear mite ( Otodectes cynotis ) infestations. revolution® PLUS kills adult fleas ( Ctenocephalides felis ) and is indicated for the treatment and prevention of flea infestations, the prevention of Dipylidium caninum (tapeworm) infections as a direct result of killing Ctenocephalides felis vector fleas on the treated cat, and the treatment and control of tick infestations with Amblyomma americanum (lone star tick), Amblyomma maculatum (Gulf Coast tick), Dermacentor variabilis (American dog tick), and Ixodes scapularis (black-legged tick) for one month in cats and kittens 8 weeks and older, and weighing 2.8 pounds or greater.
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in sick, debilitated, or underweight animals.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 56 and Cat 56 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Chihuahua, Unknown, 6 year, 2.722 kilogram • Drug: MSK, Solution, Topical, Dose: 1 dose per animal • Reactions: Lack of efficacy (ectoparasite) - flea, Underdose, Intentional misuse • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-054868
- Serious AE: No
- Treated For AE: No
- Sex: Unknown
- Age: 6.00 Year
- Weight: 2.722 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Topical
- Form: Solution
- Dose: 1 dose per animal
Cat, Cat (other), Male, 13 year, 3.49 kilogram • Drug: MSK, Unknown • Reactions: Slow heart rate, Recovery prolonged • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-055510
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 13.00 Year
- Weight: 3.490 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Cat, Domestic Shorthair, Male, 6 year, 9.525 kilogram • Drug: MSK, Solution, Topical, Dose: 60 Milligram per animal • Reactions: Hair loss at application site, Application site lesion • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-055202
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 6.00 Year
- Weight: 9.525 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Topical
- Form: Solution
- Dose: 60 Milligram per animal
Cat, Domestic Shorthair, Male, 14.5 week, 1.87 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - tapeworm • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055700
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 14.50 Week
- Weight: 1.870 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Cat, Domestic Shorthair, Male, 7 week, 0.73 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - tapeworm • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055999
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 7.00 Week
- Weight: 0.730 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Dog, ['Retriever - Labrador', 'Dog (unknown)'], Male, 4 year, 36.287 kilogram • Drug: MSK, Solution, Topical, Dose: 240 Milligram per animal • Reactions: Lack of efficacy (ectoparasite) - flea • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055014
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 4.00 Year
- Weight: 36.287 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Topical
- Form: Solution
- Dose: 240 Milligram per animal
Cat, Domestic Longhair, Male, 14.2 year, 6.895 kilogram • Drug: MSK, Solution, Topical • Reactions: Skin scab, Itching, Abnormal cytology • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055194
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 14.20 Year
- Weight: 6.895 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Topical
- Form: Solution
Dog, Terrier (unspecified), Male, 9 month, 2.812 kilogram • Drug: MSK, Solution, Topical, Dose: 1 dose per animal • Reactions: Lack of efficacy (endoparasite) - hookworm, Intentional misuse • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055260
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 9.00 Month
- Weight: 2.812 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Topical
- Form: Solution
- Dose: 1 dose per animal
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.